XXIII. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung

Ackermann, S

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Plk1 is a novel target for high-risk neuroblastoma therapy

Altvater, B

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Amann, G

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Ambros, I

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Ambros, IM

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Ambros, P

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Ambros, PF

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Armeanu-Ebinger, S

Expression and functional role of miR-200c in rhabdomyosarcoma

Development of a drug resistance model in hepatoblastoma

Asgharzadeh, S

Gene expression-based classification improves risk estimation of neuroblastoma patients

Astrahantseff, K

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

Attarbaschi, A

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Avigad, S

Gene expression-based classification improves risk estimation of neuroblastoma patients

Bachmann, H

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Bartram, T

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Baskova, L

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Baumann, M

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Bénard, J

Gene expression-based classification improves risk estimation of neuroblastoma patients

Bender, S

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Bendrat, E

Modulation of DNA repair systems by the essential melanocyte transcription factor Microphthalmia

Berger, M

Characterization of EWS-FLI1 fusion sites in Ewing sarcomas

Bernroitner, M

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Berthold, F

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Plk1 is a novel target for high-risk neuroblastoma therapy

Gene expression-based classification improves risk estimation of neuroblastoma patients

Beutel, K

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Binder, H

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Boehme, J

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Boehringer, J

Special aspects of stem cell therapy in patients with MLD

Bogen, D

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Bomken, S

ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes

Bonin, M

Expression and functional role of miR-200c in rhabdomyosarcoma

Boos, J

Methylation profiling by direct sequencing

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Borkhardt, A

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Braeuninger, A

Characterization of EWS-FLI1 fusion sites in Ewing sarcomas

Breithaupt, P

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Brockmeyer, B

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Brors, B

Gene expression-based classification improves risk estimation of neuroblastoma patients

Brunner, B

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Burghoff, S

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Büttner, R

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Cario, G

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Christiansen, H

Gene expression-based classification improves risk estimation of neuroblastoma patients

Cin, H

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Corbacioglu, S

Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients

Debatin, KM

High fidelity of phenotype and genotype in serial NOD/SCID pediatric acute lymphoblastic leukemia

Intact apoptosis signaling in pediatric ALL is associated with patient outcome, low expression of anti-apoptotic molecules and long NOD/SCID engraftment

Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

DeCarolis, B

Gene expression-based classification improves risk estimation of neuroblastoma patients

Degen, S

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

Degistirici, O

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Deimling, A von

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Delattre, O

Gene expression-based classification improves risk estimation of neuroblastoma patients

Dewerth, A

Development of a drug resistance model in hepatoblastoma

Dierk, K

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Dingermann, T

Functional analysis of the novel MLH1·ITGA9 fusion protein of a Lynch syndrome family

The dimerization domains of MLL are potential therapeutic targets in t(4;11)-leukemias

Taspase1: unraveling its control mechanisms

Dirksen, U

Characterization of EWS-FLI1 fusion sites in Ewing sarcomas

Doering, M

Special aspects of stem cell therapy in patients with MLD

Dworzak, M

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Eckardt, L

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Eckert, C

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Eckhoff, SM

High fidelity of phenotype and genotype in serial NOD/SCID pediatric acute lymphoblastic leukemia

Intact apoptosis signaling in pediatric ALL is associated with patient outcome, low expression of anti-apoptotic molecules and long NOD/SCID engraftment

Eggert, A

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

Plk1 is a novel target for high-risk neuroblastoma therapy

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Ehemann, V

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Plk1 is a novel target for high-risk neuroblastoma therapy

Ehl, S

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Eicher, C

Development of a drug resistance model in hepatoblastoma

Eils, R

Gene expression-based classification improves risk estimation of neuroblastoma patients

Erbacher, A

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Erichsen, J

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Evans, RM

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Eyrich, M

Influence of cytokines on patient survival after allogeneic transplantation

Faber, C

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

Fakler, M

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Faldum, A

Gene expression-based classification improves risk estimation of neuroblastoma patients

Feldmann, S

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Felsberg, J

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Fischer, M

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Plk1 is a novel target for high-risk neuroblastoma therapy

Gene expression-based classification improves risk estimation of neuroblastoma patients

Fruehwald, M

Methylation profiling by direct sequencing

DNA methylation in AT/RT

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Fuchs, J

Expression and functional role of miR-200c in rhabdomyosarcoma

Development of a drug resistance model in hepatoblastoma

Fuka, G

Evaluation of p53 function in ETV6/RUNX1 positive leukemia

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Fulda, S

Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Garrido Castro, P

ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes

Gasser, J

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Geppert, T

Taspase1: unraveling its control mechanisms

Giese, A

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Gieseke, F

Special aspects of stem cell therapy in patients with MLD

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Goeser, F

Plk1 is a novel target for high-risk neuroblastoma therapy

Goidts, V

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Gondesen, I

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Greil, J

ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes

Griffiths, G

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Groenhagen, A

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Grundy, RG

Gene expression-based classification improves risk estimation of neuroblastoma patients

Haas, OA

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Hagemeier, C

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Hagl, B

BMP2 is silenced by promoter hypermethylation in rhabdomyosarcoma cell lines

Handgretinger, R

Special aspects of stem cell therapy in patients with MLD

Effect of the HDAC inhibitor SAHA on the immunomodulatory properties of MSC and tumor stroma cells

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Harbott, J

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Hartwig, NG

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Haschke, A

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Heiden, T

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Heidenreich, O

ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes

Hempel, G

Methylation profiling by direct sequencing

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Hennies, HC

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Henze, G

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Hero, B

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Plk1 is a novel target for high-risk neuroblastoma therapy

Gene expression-based classification improves risk estimation of neuroblastoma patients

Herrmann, D

Expression and functional role of miR-200c in rhabdomyosarcoma

Heukamp, LC

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Hoellerhage, C

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Hof, J

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Hombach, A

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Horstmann, M

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Modulation of DNA repair systems by the essential melanocyte transcription factor Microphthalmia

Hotfilder, M

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

Hsieh, J

Functional analysis of the novel MLH1·ITGA9 fusion protein of a Lynch syndrome family

Jaeger, BAS

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Janoueix-Lerosey, I

Gene expression-based classification improves risk estimation of neuroblastoma patients

Janzarik, W

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Jeremias, I

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Johann, PD

Effect of the HDAC inhibitor SAHA on the immunomodulatory properties of MSC and tumor stroma cells

Juergens, H

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

DNA methylation in AT/RT

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Junk, S

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Juraeva, D

Gene expression-based classification improves risk estimation of neuroblastoma patients

Kaderali, L

Gene expression-based classification improves risk estimation of neuroblastoma patients

Kahlert, Y

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Gene expression-based classification improves risk estimation of neuroblastoma patients

Kailayangiri, S

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Kaindl, U

Evaluation of p53 function in ETV6/RUNX1 positive leukemia

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Kantner, H

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Kappler, R

BMP2 is silenced by promoter hypermethylation in rhabdomyosarcoma cell lines

Karathanassi, A

Characterization of medulloblastoma tumor stem cells

Karl, M

Identification of genomic fusion-sites in BCR-ABL positive childhood CML

Kauer, M

Evaluation of p53 function in ETV6/RUNX1 positive leukemia

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Khan, J

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Kirchner, B

Development of a drug resistance model in hepatoblastoma

Kirschner-Schwabe, R

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Klopocki, E

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Kocak, H

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Koch, F

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Koenig, M

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Koerner, G

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Körner, G

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Korshunov, A

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Kowalska, A

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Krapf, G

Evaluation of p53 function in ETV6/RUNX1 positive leukemia

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Krehan, D

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Krentz, S

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Kruchen, A

Effect of the HDAC inhibitor SAHA on the immunomodulatory properties of MSC and tumor stroma cells

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Krumbholz, M

Characterization of EWS-FLI1 fusion sites in Ewing sarcomas

Identification of genomic fusion-sites in BCR-ABL positive childhood CML

Kuhfittig-Kulle, S

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

Kulozik, A

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Künkele, A

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Kustermann-Kuhn, B

Special aspects of stem cell therapy in patients with MLD

Ladenstein, R

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Landlinger, C

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Landmeier, S

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Lauten, M

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Lechtape, B

Methylation profiling by direct sequencing

Leuchte, K

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Leuschner, I

Expression and functional role of miR-200c in rhabdomyosarcoma

Lichter, P

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Liebsch, L

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

Lion, T

Analysis of mutations in the BCR-ABL TK domain in CML patients

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Loeder, S

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Mang, P

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Marschalek, R

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Functional analysis of the novel MLH1·ITGA9 fusion protein of a Lynch syndrome family

The dimerization domains of MLL are potential therapeutic targets in t(4;11)-leukemias

Taspase1: unraveling its control mechanisms

Marschall, T

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Martin, M

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Martinsson, T

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Meisel, R

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Meissner, B

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Mestdagh, P

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Metzler, M

Characterization of EWS-FLI1 fusion sites in Ewing sarcomas

Identification of genomic fusion-sites in BCR-ABL positive childhood CML

Meyer, C

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Functional analysis of the novel MLH1·ITGA9 fusion protein of a Lynch syndrome family

Meyer, LH

High fidelity of phenotype and genotype in serial NOD/SCID pediatric acute lymphoblastic leukemia

Intact apoptosis signaling in pediatric ALL is associated with patient outcome, low expression of anti-apoptotic molecules and long NOD/SCID engraftment

Meyr, F

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Milde, T

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Moericke, A

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Muehlisch, J

Methylation profiling by direct sequencing

DNA methylation in AT/RT

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Mueller, I

Special aspects of stem cell therapy in patients with MLD

Effect of the HDAC inhibitor SAHA on the immunomodulatory properties of MSC and tumor stroma cells

Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice

Mundlos, S

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Nebral, K

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Neßlboeck, M

Analysis of mutations in the BCR-ABL TK domain in CML patients

Neuhoff, N von

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Niemann, A

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Niggli, F

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Noguera, R

Gene expression-based classification improves risk estimation of neuroblastoma patients

Nonnenmacher, L

Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients

Nu Van Anh, T

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Oberthuer, A

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Gene expression-based classification improves risk estimation of neuroblastoma patients

Ocampo-Bayuga, C

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Odenthal, M

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Oehm, C

The dimerization domains of MLL are potential therapeutic targets in t(4;11)-leukemias

Olbrich, H

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Omran, H

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Ostermann, B

DNA methylation in AT/RT

Pagel, J

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

Pajtler, K

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Panzer-Gruemayer, R

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Evaluation of p53 function in ETV6/RUNX1 positive leukemia

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Pfister, S

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Pietsch, T

c-Kit gene mutations in intracranial germ cell tumors

Characterization of medulloblastoma tumor stem cells

Piqueras, M

Gene expression-based classification improves risk estimation of neuroblastoma patients

Pleier, S

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Pless, B

The dimerization domains of MLL are potential therapeutic targets in t(4;11)-leukemias

Prall, S

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Preuner, S

Analysis of mutations in the BCR-ABL TK domain in CML patients

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Pscherer, S

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Queudeville, M

High fidelity of phenotype and genotype in serial NOD/SCID pediatric acute lymphoblastic leukemia

Intact apoptosis signaling in pediatric ALL is associated with patient outcome, low expression of anti-apoptotic molecules and long NOD/SCID engraftment

Rahmann, S

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Reifenberger, G

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Remke, M

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Rieder, D

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Roettgers, S

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Rosenstiel, P

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Rossig, C

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

γδ T cells: Stimulators of specific CD8+ T cell responses to sarcoma-associated antigens

Ryzhova, M

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Sabiani, S

Taspase1: unraveling its control mechanisms

Sandhu, JK

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Scaruffi, P

Gene expression-based classification improves risk estimation of neuroblastoma patients

Schardt, K

Gene expression-based classification improves risk estimation of neuroblastoma patients

Schlegel, P

Influence of cytokines on patient survival after allogeneic transplantation

Schlegelberger, B

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Schleiermacher, G

Gene expression-based classification improves risk estimation of neuroblastoma patients

Schlierf, S

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Schmidt, O

c-Kit gene mutations in intracranial germ cell tumors

Schneider, G

Taspase1: unraveling its control mechanisms

Schneider, K

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Schrader, J

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Schramm, A

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Schrappe, M

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Schrauder, A

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Schreiber, S

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Schulte, J

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Plk1 is a novel target for high-risk neuroblastoma therapy

Schulte, JH

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Schwab, M

Gene expression-based classification improves risk estimation of neuroblastoma patients

Schwarzberg, K

Modulation of DNA repair systems by the essential melanocyte transcription factor Microphthalmia

Schweinitz, D von

BMP2 is silenced by promoter hypermethylation in rhabdomyosarcoma cell lines

Seeger, K

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Seeger, R

Gene expression-based classification improves risk estimation of neuroblastoma patients

Seitz, G

Expression and functional role of miR-200c in rhabdomyosarcoma

Seyfried, F

Intact apoptosis signaling in pediatric ALL is associated with patient outcome, low expression of anti-apoptotic molecules and long NOD/SCID engraftment

Siepermann, M

CD73-mediated adenosine generation – a novel metabolic pathway of MSC-mediated immunosuppression

Siffert, W

A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Simon, T

Gene expression-based classification improves risk estimation of neuroblastoma patients

Singh, R

Finding the key of antifolate virtue – investigation of effects on the epigenetic level

Speleman, F

Gene expression-based classification improves risk estimation of neuroblastoma patients

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Spitz, R

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Spuller, E

Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma

Stackelberg, A von

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Stanulla, M

C20orf94 deletion is frequently associated with TEL/AML1 positive childhood ALL and mediated by illegitimate V(D)J recombination

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

Steiger, B

c-Kit gene mutations in intracranial germ cell tumors

Steinhoff, C

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Sternsdorf, T

Positive evidence for a role of the PML pathway in leukemogenesis of acute promyelocytic leukemia

Stoiber, D

shRNA-mediated silencing reveals distinct functions of ETV6/RUNX1 in leukemia

Strehl, S

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Sturm, D

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Suttorp, M

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Suttrop, M

Identification of genomic fusion-sites in BCR-ABL positive childhood CML

Taschner-Mandl, S

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Tauer, J

Identification of genomic fusion-sites in BCR-ABL positive childhood CML

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Tauer, JT

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Teigler-Schlegel, A

Dic(9;20)(p13;q11)-positive B-cell precursor acute lymphoblastic leukemia: A genetic and clinical entity?

Theissen, J

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

Gene expression-based classification improves risk estimation of neuroblastoma patients

Theißen, J

Ultra-high resolution 1M array CGH analysis detects no formerly unknown aberration of 17q unaltered neuroblastomas

Thiede, C

Effect and side effects of treating chronic myeloid leukemia (CML) by imatinib in pediatric patients

Thor, T

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Tonini, GP

Gene expression-based classification improves risk estimation of neuroblastoma patients

Trajanoski, Z

Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells – a new therapeutic strategy?

Troitier, F

Prevalence and prognostic significance of chromosome 21 amplifications in children with relapsed acute lymphoblastic leukemia: the ALL-REZ BFM study group

Ullmann, R

Clinical relevance of glucocorticoid receptor gene deletions in relapses of TEL-AML1 positive pediatric acute lymphoblastic leukemias

Vaegler, M

Special aspects of stem cell therapy in patients with MLD

Vaitl, J

Bone mineral aposition rates in juvenile mice exposed to long-term imatinib

Valent, A

Gene expression-based classification improves risk estimation of neuroblastoma patients

van den Heuvel, MM

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

Vandesompele, J

Deep sequencing of the small-RNA transcriptome reveals differenzial expression of microRNAs in high-risk versus low-risk neuroblastoma

Gene expression-based classification improves risk estimation of neuroblastoma patients

Van Grotel, M

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in pediatric patients undergoing intensive chemotherapy or allogeneic stem cell transplantion

van Schewick, C

Alterations of TP53 are associated with poor outcome in relapsed childhood acute lymphoblastic leukemia

Vermeulen, J

Gene expression-based classification improves risk estimation of neuroblastoma patients

Vieth, V

STEAP1-specific T cells for immunotherapy of Ewing sarcoma

Vogler, M

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for apoptosis induction and break Bcl-2-mediated resistance

Vormoor, HJ

ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes

Warmann, S

Expression and functional role of miR-200c in rhabdomyosarcoma

Warmann, SW

Development of a drug resistance model in hepatoblastoma

Warnat, P

Gene expression-based classification improves risk estimation of neuroblastoma patients

Warthorst, U

Methylation profiling by direct sequencing

Weber, A

Gene expression-based classification improves risk estimation of neuroblastoma patients

Weingarten, C

KDM1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursors

Westermann, F

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

Gene expression-based classification improves risk estimation of neuroblastoma patients

Westhoff, MA

Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients

Wiegering, V

Influence of cytokines on patient survival after allogeneic transplantation

Winkler, B

Influence of cytokines on patient survival after allogeneic transplantation

Witt, H

The kinocilia marker WDR16 as a prognostic molecular marker in pediatric ependymoma

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

SGK1– a novel prognostic marker & potential drug target in medulloblastoma

Witt, O

Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

Wittner, N

Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells

Wolf, S

BMP2 is silenced by promoter hypermethylation in rhabdomyosarcoma cell lines

Yaniv, I

Gene expression-based classification improves risk estimation of neuroblastoma patients

Zimmermann, M

Clinical and molecular characterization of therapy-related myeloid neoplasms after treatment for childhood acute lymphoblastic leukemia

zur Stadt, U

Functional characterisation of Munc18–2 missense mutations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)